This is a Validated Antibody Database (VAD) review about human KIR3DL1, based on 17 published articles (read how Labome selects the articles), using KIR3DL1 antibody in all methods. It is aimed to help Labome visitors find the most suited KIR3DL1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KIR3DL1 synonym: CD158E1; KIR; KIR3DL1/S1; NKAT-3; NKAT3; NKB1; NKB1B

BioLegend
mouse monoclonal (DX9)
  • flow cytometry; human; loading ...
BioLegend KIR3DL1 antibody (BioLegend, DX9) was used in flow cytometry on human samples . J Exp Med (2020) ncbi
mouse monoclonal (DX9)
  • flow cytometry; human; loading ...; fig 3c
BioLegend KIR3DL1 antibody (BioLegend, DX9) was used in flow cytometry on human samples (fig 3c). J Infect Dis (2019) ncbi
mouse monoclonal (DX9)
  • flow cytometry; human; loading ...; fig 4e
BioLegend KIR3DL1 antibody (Biolegend, DX9) was used in flow cytometry on human samples (fig 4e). Cancer Immunol Immunother (2018) ncbi
mouse monoclonal (DX9)
  • flow cytometry; human; loading ...; fig 1a
BioLegend KIR3DL1 antibody (BioLegend, DX9) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (DX9)
  • mass cytometry; human; loading ...; fig 4f
BioLegend KIR3DL1 antibody (Biolegend, DX9) was used in mass cytometry on human samples (fig 4f). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (DX9)
  • flow cytometry; human; loading ...; fig s1
BioLegend KIR3DL1 antibody (Biolegend, DX9) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2018) ncbi
mouse monoclonal (DX9)
  • flow cytometry; human; fig 1e
In order to investigate the role of Eomes in the retention of liver natural killer cells, BioLegend KIR3DL1 antibody (BioLegend, DX9) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (DX9)
  • flow cytometry; human; loading ...; fig 2b
BioLegend KIR3DL1 antibody (BioLegend, DX9) was used in flow cytometry on human samples (fig 2b). PLoS ONE (2016) ncbi
mouse monoclonal (DX9)
  • flow cytometry; human; loading ...; fig s1
BioLegend KIR3DL1 antibody (BioLegend, DX9) was used in flow cytometry on human samples (fig s1). J Clin Invest (2016) ncbi
mouse monoclonal (DX9)
  • flow cytometry; human; fig 6
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend KIR3DL1 antibody (Biolegend, DX9) was used in flow cytometry on human samples (fig 6). Mucosal Immunol (2016) ncbi
mouse monoclonal (DX9)
  • flow cytometry; human
BioLegend KIR3DL1 antibody (Biolegend, DX9) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (DX9)
BioLegend KIR3DL1 antibody (Biolegend, DX9) was used . Biol Blood Marrow Transplant (2014) ncbi
mouse monoclonal (DX9)
  • flow cytometry; human
BioLegend KIR3DL1 antibody (Biolegend, clone DX-9) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
Miltenyi Biotec
human monoclonal (REA168)
  • flow cytometry; human; loading ...; fig 2b
Miltenyi Biotec KIR3DL1 antibody (Miltenyi Biotec, REA168) was used in flow cytometry on human samples (fig 2b). J Immunol (2018) ncbi
human monoclonal (REA168)
  • other; human; loading ...; fig 6a
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, Miltenyi Biotec KIR3DL1 antibody (Miltenyi Biotec, 130-104-483) was used in other on human samples (fig 6a). Immunity (2017) ncbi
mouse monoclonal (5.133)
  • other; human; loading ...; fig 6a
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, Miltenyi Biotec KIR3DL1 antibody (Miltenyi Biotec, 130-095-201) was used in other on human samples (fig 6a). Immunity (2017) ncbi
Beckman Coulter
mouse monoclonal (Z27.3.7)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter KIR3DL1 antibody (Beckman Coulter, Z27.3.7) was used in flow cytometry on human samples (fig 3b). Immun Ageing (2017) ncbi
BD Biosciences
mouse monoclonal (DX9)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences KIR3DL1 antibody (BD, 555967) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
Articles Reviewed
  1. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed publisher
  2. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed publisher
  3. Kiani Z, Dupuy F, Bruneau J, Lebouché B, Zhang C, Jackson E, et al. HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1. J Immunol. 2018;201:113-123 pubmed publisher
  4. Nguyen R, Houston J, Chan W, Finkelstein D, Dyer M. The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma. Cancer Immunol Immunother. 2018;67:615-626 pubmed publisher
  5. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  6. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  7. Chan Y, Zuo J, Inman C, Croft W, Begum J, Croudace J, et al. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur J Immunol. 2018;48:316-329 pubmed publisher
  8. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  9. van der Geest K, Wang Q, Eijsvogels T, Koenen H, Joosten I, Brouwer E, et al. Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study. Immun Ageing. 2017;14:5 pubmed publisher
  10. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  11. Isitman G, Tremblay McLean A, Lisovsky I, Bruneau J, Lebouché B, Routy J, et al. NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts. PLoS ONE. 2016;11:e0164517 pubmed publisher
  12. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed publisher
  13. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  14. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  15. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed publisher
  16. Miller J, Rooney C, Curtsinger J, McElmurry R, McCullar V, Verneris M, et al. Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy. Biol Blood Marrow Transplant. 2014;20:1252-7 pubmed publisher
  17. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher